Rize Oncology Inc (RIZE.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,162 | 1,364 | 1,796 | 180 | 45 |
| Receivables | 30 | 47 | 148 | N/A | N/A |
| Other current assets | 0 | 0 | 0 | 191 | 0 |
| TOTAL | $1,192 | $1,411 | $1,944 | $370 | $45 |
| Non-Current Assets | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $1,192 | $1,411 | $1,944 | $370 | $45 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 122 |
| Accounts payable and accrued liabilities | 83 | 39 | 87 | 213 | 1 |
| TOTAL | $83 | $39 | $87 | $213 | $123 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $83 | $39 | $87 | $213 | $123 |
| Shareholders' Equity | |||||
| Common Shares | 4,197 | 4,197 | 4,175 | 1,248 | 164 |
| Retained earnings | -4,833 | -4,283 | -3,594 | -1,879 | -241 |
| Other shareholders' equity | 87 | -175 | -201 | 0 | 0 |
| TOTAL | $1,109 | $1,372 | $1,857 | $157 | $-78 |
| Total Liabilities And Equity | $1,192 | $1,411 | $1,944 | $370 | $45 |